Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma - Poll - MDSpire

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

  • By

  • Tim Richardson

  • Hishan Tharmaseelan

  • Lukas Frenzel

  • Philipp Gödel

  • Moritz Fürstenau

  • Pascal Nieper

  • Till Braun

  • Daniel Schütte

  • Michael Hallek

  • Christof Scheid

  • Udo Holtick

  • November 15, 2024

  • 0 min

Share

Original Source(s)

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

  • by Tim Richardson, Hishan Tharmaseelan, Lukas Frenzel, Philipp Gödel, Moritz Fürstenau, Pascal Nieper, Till Braun, Daniel Schütte, Michael Hallek, Christof Scheid, Udo Holtick

  • November 15, 2024

Related Content

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

  • by

  • May 25, 2026

  • 9 min
Hodgkin lymphoma with hypereosinophilia in a pediatric patient: case report and review of the literature

Platelet extravasation in the microvasculature: an under-appreciated role for platelets